Dr James Nicholson - Publications
Frazier L, Hale JP, Rodriguez-Galindo C, Dang H, Olson T, Murray M, Amatruda JF, Thornton C, Arul GS, Billmire D, Shaikh F, Pashankar F, Stoneham S, Krailo M, Nicholson JC. Revised Risk Classification for Pediatric Extracranial Germ Cell Tumors Based on 25 Years of Clinical Trial Data from the United Kingdom and United States. J Clin Oncol. 2015, Jan 10;33(2):195-201
View publication
01 Dec 2014
Murray MJ, Bartels U, Nishikawa R, Fangusaro J, Matsutani M, Nicholson JC. 'Consensus in the management of intracranial germ-cell tumours'. Lancet Oncol. 2015 Sep;16(9):e470-7.
View publication
01 Sep 2015
Calaminus G, Frappaz D, Kortmann R, Krefeld B, Saran F, Pietsch T, Vasiljevic A, Garre M, Ricardi U, Mann J, Göbel U, Alapetite C, Murray MJ, Nicholson JC. Outcome of patients with intracranial non-germinomatous germ cell tumors – lessons from the SIOP-CNS-GCT-96 trial. Neuro Oncol. 2017 Nov 29;19(12):1661-1672.
View publication
05 Jul 2017
Murray MJ, Bailey S, Heinemann K, Mann J, Göbel UK, Saran F, Hale JP, Calaminus G, Nicholson JC. Treatment and outcomes of UK and German patients with relapsed intracranial germ cell tumors following uniform first-line therapy. Int J Cancer 2017 Aug 1;141(3):621-635.
View publication
15 May 2017
Frazier L, Stoneham S, Rodriguez-Galindo C, Dang H; Xia C, Olson T, Murray MJ, Amatruda J, Arul GS, Shaikh F, Billmire D, Krailo M, Stark D, Brougham M, Nicholson JC, Hale JP. Comparison of Carboplatin vs. Cisplatin in the Treatment of Paediatric Malignant Germ Cell Tumours: A Report of the Malignant Germ Cell International Consortium. Eur J Cancer, 2018 Jul;98:30-37
View publication
01 Jul 2018
S Depani S, Stoneham S, Krailo M, Xia C, Nicholson J. Results from the UK Children's Cancer and Leukaemia Group study of extracranial germ cell tumours in Children & Adolescents (GC3). Eur J Cancer. 2019 Sep;118:49-57
View publication
12 Jul 2019
Murray MJ, Ajithkumar T, Harris F, Williams R, Jalloh I, Cross J, Rhonge M, Ward D, Scarpini C, Nicholson JC+ and Coleman N+ (+ equal contrib). Clinical utility of circulating miR-371a-3p for management of patients with intracranial malignant GCTs. Neuro-oncology Adv, 2020 Apr 13, 2(1),1-10
View publication
01 Apr 2020
Calaminus G, Bison B, Conter C, Frappaz D, Peyrl A, Gerber N, Müller J-E, Ajithkumar TV, Mitra D, Cross J, Pietsch T, Smith C, Solem K, Devenney I, Garre M, Brisse H, Zimmermann M, Kortmann R, Alapetite C, Nicholson J. 24Gy whole ventricular radiotherapy alone is sufficient for disease control in localised Germinoma in CR after initial chemotherapy – early results of the SIOP CNS GCT II study. Neuro-Oncology vol 22 Supp 3, Dec 2020, p343-344
View publication
01 Dec 2020
Murray MJ, Ruffle A, Lowis S, Howell L, Shanmugavadivel D, Dommett R, Gamble A, Shenton G, Nicholson JC. A Delphi method to identify expert opinion to support children’s cancer referral guidelines. Arch Dis Child. Arch Dis Child. 2020 Mar;105(3):241-246.
View publication
01 Mar 2020
Murray MJ, Moleron R, Adamski J, English M, Burke GAA, Cross J, Ajithkumar T, Stoneham S, Nicholson JC. Vinblastine monotherapy induction prior to radiotherapy for patients with intracranial Germinoma during the COVID-19 pandemic. Pediatr Blood Cancer.2022 Jan;69(1):e29359. doi: 10.1002/pbc.29359. Epub 2021 Sep 14
View publication
01 Jan 2022
View publication
01 Dec 2014
Murray MJ, Bartels U, Nishikawa R, Fangusaro J, Matsutani M, Nicholson JC. 'Consensus in the management of intracranial germ-cell tumours'. Lancet Oncol. 2015 Sep;16(9):e470-7.
View publication
01 Sep 2015
Calaminus G, Frappaz D, Kortmann R, Krefeld B, Saran F, Pietsch T, Vasiljevic A, Garre M, Ricardi U, Mann J, Göbel U, Alapetite C, Murray MJ, Nicholson JC. Outcome of patients with intracranial non-germinomatous germ cell tumors – lessons from the SIOP-CNS-GCT-96 trial. Neuro Oncol. 2017 Nov 29;19(12):1661-1672.
View publication
05 Jul 2017
Murray MJ, Bailey S, Heinemann K, Mann J, Göbel UK, Saran F, Hale JP, Calaminus G, Nicholson JC. Treatment and outcomes of UK and German patients with relapsed intracranial germ cell tumors following uniform first-line therapy. Int J Cancer 2017 Aug 1;141(3):621-635.
View publication
15 May 2017
Frazier L, Stoneham S, Rodriguez-Galindo C, Dang H; Xia C, Olson T, Murray MJ, Amatruda J, Arul GS, Shaikh F, Billmire D, Krailo M, Stark D, Brougham M, Nicholson JC, Hale JP. Comparison of Carboplatin vs. Cisplatin in the Treatment of Paediatric Malignant Germ Cell Tumours: A Report of the Malignant Germ Cell International Consortium. Eur J Cancer, 2018 Jul;98:30-37
View publication
01 Jul 2018
S Depani S, Stoneham S, Krailo M, Xia C, Nicholson J. Results from the UK Children's Cancer and Leukaemia Group study of extracranial germ cell tumours in Children & Adolescents (GC3). Eur J Cancer. 2019 Sep;118:49-57
View publication
12 Jul 2019
Murray MJ, Ajithkumar T, Harris F, Williams R, Jalloh I, Cross J, Rhonge M, Ward D, Scarpini C, Nicholson JC+ and Coleman N+ (+ equal contrib). Clinical utility of circulating miR-371a-3p for management of patients with intracranial malignant GCTs. Neuro-oncology Adv, 2020 Apr 13, 2(1),1-10
View publication
01 Apr 2020
Calaminus G, Bison B, Conter C, Frappaz D, Peyrl A, Gerber N, Müller J-E, Ajithkumar TV, Mitra D, Cross J, Pietsch T, Smith C, Solem K, Devenney I, Garre M, Brisse H, Zimmermann M, Kortmann R, Alapetite C, Nicholson J. 24Gy whole ventricular radiotherapy alone is sufficient for disease control in localised Germinoma in CR after initial chemotherapy – early results of the SIOP CNS GCT II study. Neuro-Oncology vol 22 Supp 3, Dec 2020, p343-344
View publication
01 Dec 2020
Murray MJ, Ruffle A, Lowis S, Howell L, Shanmugavadivel D, Dommett R, Gamble A, Shenton G, Nicholson JC. A Delphi method to identify expert opinion to support children’s cancer referral guidelines. Arch Dis Child. Arch Dis Child. 2020 Mar;105(3):241-246.
View publication
01 Mar 2020
Murray MJ, Moleron R, Adamski J, English M, Burke GAA, Cross J, Ajithkumar T, Stoneham S, Nicholson JC. Vinblastine monotherapy induction prior to radiotherapy for patients with intracranial Germinoma during the COVID-19 pandemic. Pediatr Blood Cancer.2022 Jan;69(1):e29359. doi: 10.1002/pbc.29359. Epub 2021 Sep 14
View publication
01 Jan 2022